A new treatment option is available for patients battling metastatic prostate cancer. Pluvicto, a targeted radioactive treatment, has been introduced at Piedmont Fayette Hospital. This treatment is specifically designed for patients with this type of cancer.

Further details about Pluvicto and its potential benefits are available from the source. The treatment is targeted, using radioactive properties to combat the disease.

An 86-year-old golfer is among those battling cancer, and this new treatment may offer hope for patients like him. For more information about Pluvicto and its application, readers can consult the original source.